These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10491815)

  • 1. Saturable transport of gabapentin at the blood-brain barrier.
    Luer MS; Hamani C; Dujovny M; Gidal B; Cwik M; Deyo K; Fischer JH
    Neurol Res; 1999 Sep; 21(6):559-62. PubMed ID: 10491815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach.
    Wang Y; Welty DF
    Pharm Res; 1996 Mar; 13(3):398-403. PubMed ID: 8692732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.
    Stewart BH; Kugler AR; Thompson PR; Bockbrader HN
    Pharm Res; 1993 Feb; 10(2):276-81. PubMed ID: 8456077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate.
    Welty DF; Schielke GP; Vartanian MG; Taylor CP
    Epilepsy Res; 1993 Dec; 16(3):175-81. PubMed ID: 8119268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain microdialysis and PK/PD correlation of pregabalin in rats.
    Feng MR; Turluck D; Burleigh J; Lister R; Fan C; Middlebrook A; Taylor C; Su T
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):123-8. PubMed ID: 11554426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose gabapentin pharmacokinetics and safety in healthy infants and children.
    Haig GM; Bockbrader HN; Wesche DL; Boellner SW; Ouellet D; Brown RR; Randinitis EJ; Posvar EL
    J Clin Pharmacol; 2001 May; 41(5):507-14. PubMed ID: 11361047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a high-protein meal on gabapentin pharmacokinetics.
    Gidal BE; Maly MM; Budde J; Lensmeyer GL; Pitterle ME; Jones JC
    Epilepsy Res; 1996 Feb; 23(1):71-6. PubMed ID: 8925804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
    Ben-Menachem E; Persson LI; Hedner T
    Epilepsy Res; 1992 Mar; 11(1):45-9. PubMed ID: 1373372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal absorption of gabapentin in rats.
    Maurer HH; Rump AF
    Arzneimittelforschung; 1991 Feb; 41(2):104-6. PubMed ID: 2043169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of gabapentin.
    McLean MJ
    Neurology; 1994 Jun; 44(6 Suppl 5):S17-22; discussion S31-2. PubMed ID: 8022536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin neurotoxicity in a chronic haemodialysis patient.
    Bassilios N; Launay-Vacher V; Khoury N; Rondeau E; Deray G; Sraer JD
    Nephrol Dial Transplant; 2001 Oct; 16(10):2112-3. PubMed ID: 11572915
    [No Abstract]   [Full Text] [Related]  

  • 13. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.
    Sills GJ; Butler E; Forrest G; Ratnaraj N; Patsalos PN; Brodie MJ
    Epilepsia; 2003 Jul; 44(7):886-92. PubMed ID: 12823570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/Pharmacodynamic Relationship of Gabapentin in a CFA-induced Inflammatory Hyperalgesia Rat Model.
    Larsen MS; Keizer R; Munro G; Mørk A; Holm R; Savic R; Kreilgaard M
    Pharm Res; 2016 May; 33(5):1133-43. PubMed ID: 26780452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
    Ben-Menachem E; Söderfelt B; Hamberger A; Hedner T; Persson LI
    Epilepsy Res; 1995 Jul; 21(3):231-6. PubMed ID: 8536677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of pregabalin in rat intestine and Caco-2 monolayers.
    Jezyk N; Li C; Stewart BH; Wu X; Bockbrader HN; Fleisher D
    Pharm Res; 1999 Apr; 16(4):519-26. PubMed ID: 10227706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age and gender on single-dose pharmacokinetics of gabapentin.
    Boyd RA; Türck D; Abel RB; Sedman AJ; Bockbrader HN
    Epilepsia; 1999 Apr; 40(4):474-9. PubMed ID: 10219274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of gabapentin in anuric subjects on hemodialysis.
    Wong MO; Eldon MA; Keane WF; Türck D; Bockbrader HN; Underwood BA; Sedman AJ; Halstenson CE
    J Clin Pharmacol; 1995 Jun; 35(6):622-6. PubMed ID: 7665723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gabapentin--a new antiepileptic agent].
    Nakken KO; Rytter E; Johannessen SI
    Tidsskr Nor Laegeforen; 1998 Feb; 118(6):872-4. PubMed ID: 9543799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.